By Denny Jacob Shares of RVL Pharmaceuticals fell to a 52-week low on Thursday after disclosing that several of its operating subsidiaries are filing for.
Health-care companies fell as traders rotated out of high-risk sectors such as biotechnology. Walgreen Boots Alliance rallied after it named Cigna official.
RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Free Report) was the recipient of a significant growth in short interest in August. As of August 31st, there was short interest totalling 1,360,000 shares, a growth of 4,136.8% from the August 15th total of 32,100 shares. Approximately 1.7% of the shares of the company are short sold. Based […]
RVL Pharmaceuticals (NASDAQ:RVLP – Free Report) had its price target trimmed by HC Wainwright from $4.00 to $3.00 in a report released on Monday, Marketbeat.com reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for RVL Pharmaceuticals’ Q3 2023 earnings at ($0.10) EPS, FY2023 earnings at ($0.45) EPS, […]
RVL Pharmaceuticals plc Forecasted to Earn Q1 2024 Earnings of ($0 13) Per Share (NASDAQ:RVLP) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.